Portuguese drug company Bial has prepared a drug aimed at tackling mood and anxiety issues, as well as movement coordination disorders linked to neurological issues. The drug company conducted a clinical trial of the drug in France. In total, 90 people have taken part in the trial. It is reported that out of the 90 people, one person has been left brain dead and five others have been hospitalized after taking part in the clinical trial; all the six men aged 28 to 49 being in good health until taking the oral medication.